domvanalimab,etrumadenant,zimberelimab
arcus biosciences,gilead
['lung', 'nsclc', 'sclc', 'arc-7', ' arcus ', 'gilead']
some more interesting news from #asco23 on #tigit gilead and arcus announced updated results from the arc-7 study involving 150 patients with first-line, metastatic non-small cell lung cancer (nsclc). this trial evaluated combinations of the fc-silent 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines